Resources from the same session
Debate: Adjuvant Chemotherapy or Immune Therapy for MIBC: Adjuvant Chemotherapy
Presenter: T. Powles, UK
Session: Session 2 - Bladder Cancer - Part 2
Resources:
Slides
Webcast
Debate: Adjuvant Chemotherapy or Immune Therapy for MIBC: Immune Therapy
Presenter: M. van der Heijden, NL
Session: Session 2 - Bladder Cancer - Part 2
Resources:
Slides
Webcast
Established and Novel Neoadjuvant Treatments for MIBC
Presenter: M. van der Heijden, NL
Session: Session 2 - Bladder Cancer - Part 2
Resources:
Slides
Webcast
Sequencing Therapy in Advanced Bladder Cancer
Presenter: F. Schlürmann, FR
Session: Session 2 - Bladder Cancer - Part 2
Resources:
Slides
Webcast
Participants Clinical Case Discussion: Complication of Neo-Adjuvant Non-Standard Immunotherapy: What Can We Learn?
Presenter: J. Blanc, BE
Session: Session 2 - Bladder Cancer - Part 2
Resources:
Slides
Webcast
Participants Clinical Case Discussion: Cutaneous Toxicities Management of Enfortumab Vedotin in Metastatic Urothelial Carcinoma : Two Clinical Cases
Presenter: E. Dhamelincourt, FR
Session: Session 2 - Bladder Cancer - Part 2
Resources:
Slides
Webcast
First Line Treatment in Advanced Bladder Cancer
Presenter: T. Powles, UK
Session: Session 2 - Bladder Cancer - Part 2
Resources:
Slides
Webcast